| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/15/2023 | Adverum Biotechnologies, Inc. | ADVM | Sale | Common Stock | 13.4k | $0.78 | $10.4k | | 03/15/2023 |
| 09/19/2022 | Adverum Biotechnologies, Inc. | ADVM | Sale | Common Stock | 13.3k | $1.07 | $14.2k | | 09/19/2022 |
| 09/14/2022 | Adverum Biotechnologies, Inc. | ADVM | Grant | Performance Based Stock Option (Right to Buy) | 230.9k | $1.09 | $251.7k | | 09/14/2022 |
| 09/14/2022 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 163.8k | $1.09 | $178.6k | | 09/14/2022 |
| 04/19/2022 | Adverum Biotechnologies, Inc. | ADVM | Purchase | Common Stock | 21.8k | $1.14 | $24.8k | | 04/19/2022 |
| 04/19/2022 | Adverum Biotechnologies, Inc. | ADVM | Purchase | Common Stock | 175 | $1.14 | $199 | | 04/19/2022 |
| 03/08/2022 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 255k | $1.29 | $329k | | 03/08/2022 |
| 12/08/2021 | Adverum Biotechnologies, Inc. | ADVM | Purchase | Common Stock | 25k | $1.91 | $47.8k | | 12/08/2021 |
| 08/06/2021 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 160k | $2.48 | $396.8k | | 08/06/2021 |
| 08/06/2021 | Adverum Biotechnologies, Inc. | ADVM | Grant | Common Stock | 220k | $0.00 | $0 | | 08/06/2021 |
| 02/16/2021 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 140k | $13.44 | $1.9M | | 02/16/2021 |
| 08/17/2020 | Adverum Biotechnologies, Inc. | ADVM | Purchase | Common Stock | 7.7k | $13.00 | $100k | | 08/17/2020 |
| 02/20/2020 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 40.8k | $15.75 | $641.8k | | 02/20/2020 |
| 10/30/2019 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 400k | $6.88 | $2.8M | | 10/30/2019 |